| Submission Number |
Title |
First Author |
Institution |
| LB-0004 |
A Clinical Investigation Evaluating the Safety and Efficacy of TaurusOne TAVR System to Treat the Patients with Severe Aortic Stenosis: Methods and 30-Day Data Post Implantation |
Run-lin Gao |
FuWai Hospital |
| LB-0005 |
A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease (FUTURE-I): Three-Year Clinical and Imaging Outcomes |
Bo Xu |
Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China |
| LB-0007 |
Three-year Clinical Outcomes of Comparison Between a Sirolimus-eluting Bioresorbable Scaffold (XINSORB) And a Metallic Stent for the Treatment of Coronary Artery Stenosis. |
Yizhe Wu |
Shanghai Institute of Cardiovascular Diseases |
| LB-0009 |
A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease: Three-year Clinical Outcomes |
Han Yaling |
General Hospital of Northern Theater Command |
| LB-0010 |
Safety and Efficacy of the Novel Sirolimus-Eluting Bioresorbable Scaffold for the Treatment of De Novo Coronary Artery Disease: Two-Year Results of the NeoVas OPC Study |
Fu Guosheng |
Sir Run Run Shaw Hospital of Zhejiang University |
| LB-0014 |
Primary endpoint Outcomes of A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System) compared to TIVOLI in the Treatment of Patients with Coronary Heart Disease |
Han Yaling |
General Hospital of Northern Theater Command |
| LB-0015 |
A Prospective Multicenter Randomized Trial Assessing the Efficacy and Safety of Active Transfer of Plaque vs. Provisional T Stenting for the Treatment of Unprotected Distal Left Main Bifurcation Lesions: 1-year results |
Yang Lixia |
Beijing Anzhen Hospital |
